A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer

Clinical trial NCT07339267 · RECRUITING

Trial details

NCT number: NCT07339267
Sponsor: Astellas Pharma Global Development, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Castration-Resistant Prostate Cancer Metastatic Hormone Sensitive Prostate Cancer

Start date: 2026-01-20
Primary completion: 2028-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.